Clinical trial
Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy: A Randomized Controlled Trial
NCT07271979 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy: A Randomized Controlled Trial
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 4, 2026
- Completion date
- May 23, 2026
- Enrollment
- 146 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, liposomal bupivacaine, preperitoneal infiltration